Why Tyson Stock Is Moving Today

Tyson Foods, Inc. (NYSE: TSN) shares are trading higher.

Tyson Foods, Inc. (NYSE:TSN) shares are trading higher. The company late Friday announced a definitive agreement where Cal-Maine Foods, Inc. (NASDAQ:CALM) would acquire its recently closed facilities.

What To Know: Under the agreement, which was announced last Friday after the close of the market, Cal-Maine Foods will acquire a broiler processing plant, hatchery and feed mill in Dexter, Missouri which the company intends to repurpose for use in egg and egg products production. Cal-Maine Foods also plans to make further investments in the facilities and community.

The company expects that the transaction will close in its third-quarter.

Sherman Miller, President and CEO of Cal-Maine Foods, Inc., said, “We are pleased to announce the proposed acquisition of the assets of Tyson’s former broiler processing facility in Dexter, Missouri.”

“This transaction is consistent with our growth strategy to expand our business through selective acquisitions in addition to our organic growth initiatives. The Dexter location offers an important opportunity to expand our geographic footprint and enhance our ability to serve our valued customers with added production and distribution capabilities in Missouri and surrounding markets.”

Related Link: There’s Optimism Around Longboard Pharmaceuticals’ Anti-Seizure Candidate: Analyst Boosts Price Target

TSN, CALM Price Action: Shares of Tyson Foods were up 3.68% at $55.73 while shares of Cal-Maine Foods were down 2.96% at $55.69 at the time of publication, according to Benzinga Pro.

Image by 9883074 from Pixabay

 

 

Total
0
Shares
Related Posts
Read More

Wall Street Set To Stumble At Open As Traders Eye Key Data, Fed Chair Powell’s Speech: Analyst Finds 2 Reasons To Stay Optimistic In April

Gloom persists on Wall Street as stock futures point to a sluggish start on Wednesday, with the tech space potentially pressured by recent setbacks and the earthquake in Taiwan, home to several tech in

AMD

Read More

Inebriation Remedy And Breakthrough MS Treatment: Meet FSD Pharma

Among a biotech space bursting with innovation, one company stands out as it is developing two assets at once: a ready-for-market drink that can take someone from a drinking state to mental and physical composure in record time and a potential breakthrough therapy for Multiple Sclerosis. Meet FSD Pharma (NASDAQ:

HUGE